litlas
ログインアカウント作成

Gerd Ritter

1989–2021 年に発表

96
論文数
17,990
被引用数
78
h 指数
91
i10 指数

被引用数

Gerd Ritter の年別被引用数1990 年: 被引用 1 件1991 年: 被引用 7 件1992 年: 被引用 6 件1993 年: 被引用 11 件1994 年: 被引用 16 件1995 年: 被引用 15 件1996 年: 被引用 17 件1997 年: 被引用 20 件1998 年: 被引用 27 件1999 年: 被引用 37 件2000 年: 被引用 53 件2001 年: 被引用 84 件2002 年: 被引用 99 件2003 年: 被引用 125 件2004 年: 被引用 165 件2005 年: 被引用 178 件2006 年: 被引用 187 件2007 年: 被引用 202 件2008 年: 被引用 221 件2009 年: 被引用 216 件2010 年: 被引用 216 件2011 年: 被引用 218 件2012 年: 被引用 245 件2013 年: 被引用 210 件2014 年: 被引用 193 件2015 年: 被引用 244 件2016 年: 被引用 188 件2017 年: 被引用 186 件2018 年: 被引用 191 件2019 年: 被引用 513 件2020 年: 被引用 493 件2021 年: 被引用 444 件2022 年: 被引用 334 件2023 年: 被引用 220 件2024 年: 被引用 263 件2025 年: 被引用 122 件2026 年: 被引用 3 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,217 件、この内訳の 32.9%中国: 引用元論文 589 件、この内訳の 8.7%ドイツ: 引用元論文 398 件、この内訳の 5.9%イギリス: 引用元論文 372 件、この内訳の 5.5%オーストラリア: 引用元論文 280 件、この内訳の 4.1%日本: 引用元論文 262 件、この内訳の 3.9%フランス: 引用元論文 249 件、この内訳の 3.7%イタリア: 引用元論文 234 件、この内訳の 3.5%カナダ: 引用元論文 214 件、この内訳の 3.2%オランダ: 引用元論文 203 件、この内訳の 3%スイス: 引用元論文 193 件、この内訳の 2.9%ベルギー: 引用元論文 119 件、この内訳の 1.8%
0%32.9%その他 20.9%

機関

分野

  • Medicine40.7%
  • Immunology and Microbiology34.9%
  • Biochemistry, Genetics and Molecular Biology18.1%
  • Materials Science1.4%
  • Computer Science1.3%
  • Engineering1%
  • その他2.6%

トピック

  • Immunotherapy and Immune Responses13.1%
  • Cancer Immunotherapy and Biomarkers8.8%
  • Immune Cell Function and Interaction7.8%
  • CAR-T cell therapy research5.2%
  • T-cell and B-cell Immunology4.5%
  • Monoclonal and Polyclonal Antibodies Research3.2%
  • その他57.4%

共著者

全論文

検索で開く
  1. Intraepithelial CD8 + tumor-infiltrating lymphocytes and a high CD8 + /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

    著者: Eiichi Sato, Sara H. Olson, Jiyoung Ahn, Brian N. Bundy, Hiroyoshi Nishikawa, Feng Qian, Achim A. Jungbluth, Denise Frosina, Sacha Gnjatic, Christine B. Ambrosone, James L. Kepner, Tosin Odunsi, Gerd Ritter, Shashikant Lele, Yao‐Tseng Chen, Haruo Ohtani, Lloyd J. Old, Kunle Odunsi - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 被引用: 2,389

  2. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

    著者: Andrew M. Scott, G. Wiseman, Sydney Welt, Alex A. Adjei, Fook-Thean Lee, Wendie Hopkins, C R Divgi, Lorelei H Hanson, Paul Mitchell, Denise N. Gansen, Steven M. Larson, James N. Ingle, Eric W. Hoffman, P. Tanswell, Gerd Ritter, Leonard Cohen, Peter Bette, Lisa Arvay, A. Amelsberg, Dan Vlock, Wolfgang J. Rettig, Lloyd J. Old - 2003 被引用: 442

  3. Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity

    著者: Julia Karbach, Antje Neumann, Kathrin Brand, Claudia Wahle, Ekkehard Siegel, Markus Maeurer, Erika Ritter, Takamasa Tsuji, Sacha Gnjatic, Lloyd J. Old, Gerd Ritter, Elke Jäger - Clinical Cancer Research 2012 被引用: 99

  4. NY‐ESO‐1: Review of an Immunogenic Tumor Antigen

    著者: Sacha Gnjatic, Hiroyoshi Nishikawa, Achim A. Jungbluth, Ali O. Güre, Gerd Ritter, Elke Jäger, Alexander Knuth, Yao‐Tseng Chen, Lloyd J. Old - Advances in cancer research 2006 被引用: 455

  5. Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

    著者: Paul Sabbatini, Takemasa Tsuji, Luis Ferran, Erika Ritter, Christine Sedrak, Kevin Tuballes, Achim A. Jungbluth, Gerd Ritter, Carol Aghajanian, Katherine M. Bell‐McGuinn, Martee L. Hensley, Jason Konner, William P. Tew, David R. Spriggs, Eric W. Hoffman, Ralph Venhaus, Linda Pan, Andres Μ. Salazar, Catherine Diefenbach, Lloyd J. Old, Sacha Gnjatic - Clinical Cancer Research 2012 被引用: 273

  6. Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer

    著者: Kunle Odunsi, Junko Matsuzaki, Smitha R. James, Paulette Mhawech‐Fauceglia, Takemasa Tsuji, Austin Miller, Wa Zhang, Stacey N. Akers, Elizabeth A. Griffiths, Anthony Miliotto, Amy Beck, Carl A. Batt, Gerd Ritter, Shashikant Lele, Sacha Gnjatic, Adam R. Karpf - Cancer Immunology Research 2014 被引用: 193

  7. RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

    著者: Michael Schmitt, Anita Schmitt, Markus Rojewski, Jinfei Chen, Krzysztof Giannopoulos, Fei Fei, Yingzhe Yu, Marlies Götz, Marta Heyduk, Gerd Ritter, Daniel E. Speiser, Sacha Gnjatic, Philippe Guillaume, Mark Ringhoffer, Richard F. Schlenk, Peter Liebisch, Donald Bunjes, Hiroshi Shiku, Hartmut Döhner, Jochen Greiner - Blood 2007 被引用: 212

  8. Integrated NY-ESO-1 antibody and CD8 + T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

    著者: Jianda Yuan, Matthew Adamow, Brian Ginsberg, Teresa Rasalan, Erika Ritter, Humilidad F. Gallardo, Yinyan Xu, Evelina Pogoriler, Stephanie Terzulli, Deborah Kuk, Katherine S. Panageas, Gerd Ritter, Mario Sznol, Ruth Halaban, Achim A. Jungbluth, James P. Allison, Lloyd J. Old, Jedd D. Wolchok, Sacha Gnjatic - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 被引用: 329

  9. Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

    著者: Kunle Odunsi, Feng Qian, Junko Matsuzaki, Paulette Mhawech‐Fauceglia, Chris Andrews, Eric W. Hoffman, Linda Pan, Gerd Ritter, Jeannine Villella, Bridget V. Thomas, Kerry J. Rodabaugh, Shashikant Lele, Protul Shrikant, Lloyd J. Old, Sacha Gnjatic - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 被引用: 267

  10. A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor

    著者: Achim A. Jungbluth, Elisabeth Stockert, Hongyi Huang, V. Peter Collins, Keren Coplan, Kristin Iversen, Denise Kolb, Terrance G. Johns, Andrew M. Scott, William J. Gullick, Gerd Ritter, Leonard Cohen, Matthew J. Scanlan, Webster Cavanee, Lloyd J. Old - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 被引用: 174

  11. Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

    著者: Ali O. Güre, Ramon Chua, Barbara Williamson, Mithat Gönen, Cathy A. Ferrera, Sacha Gnjatic, Gerd Ritter, Andrew J.G. Simpson, Yao-T. Chen, Lloyd J. Old, Nasser K. Altorki - Clinical Cancer Research 2005 被引用: 364

  12. PEGylated Gold Nanoparticles Conjugated to Monoclonal F19 Antibodies as Targeted Labeling Agents for Human Pancreatic Carcinoma Tissue

    著者: Wolfgang Eck, Gary A. Craig, Aruna Sigdel, Gerd Ritter, Lloyd J. Old, Laura H. Tang, Murray F. Brennan, Peter J. Allen, Michael D. Mason - ACS Nano 2008 被引用: 277

  13. A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma

    著者: Robert G. Maki, Achim A. Jungbluth, Sacha Gnjatic, Gary K. Schwartz, David R. D’Adamo, Mary Louise Keohan, Michael J. Wagner, Kelly Scheu, Rita Chiu, Erika Ritter, Jennifer Kachel, Israel Lowy, Lloyd J. Old, Gerd Ritter - Sarcoma 2013 被引用: 180

  14. Identification of the Epitope for the Epidermal Growth Factor Receptor-specific Monoclonal Antibody 806 Reveals That It Preferentially Recognizes an Untethered Form of the Receptor

    著者: Terrance G. Johns, Timothy E. Adams, Jennifer R. Cochran, Nathan E. Hall, Peter A. Hoyne, Mark Olsen, Yong‐Sung Kim, Julie Rothacker, Edouard C. Nice, Francesca Walker, Gerd Ritter, Achim A. Jungbluth, Lloyd J. Old, Colin W. Ward, Antony W. Burgess, K. Dane Wittrup, Andrew M. Scott - Journal of Biological Chemistry 2004 被引用: 146

  15. CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

    著者: Jianda Yuan, Sacha Gnjatic, Hao Li, Sarah Powel, Humilidad F. Gallardo, Erika Ritter, Geoffrey Y. Ku, Achim A. Jungbluth, Neil H. Segal, Teresa Rasalan, Gregor Manukian, Yinyan Xu, Ruth-Ann Roman, Stephanie Terzulli, Melanie Heywood, Evelina Pogoriler, Gerd Ritter, Lloyd J. Old, James P. Allison, Jedd D. Wolchok - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 被引用: 342

  16. Frequent and specific immunity to the embryonal stem cell–associated antigen SOX2 in patients with monoclonal gammopathy

    著者: Radek Špíšek, Anjli Kukreja, Lin-Chi Chen, Phillip Matthews, Amitabha Mazumder, David H. Vesole, Sundar Jagannath, Henry Zebroski, Andrew J.G. Simpson, Gerd Ritter, Brian G.M. Durie, John Crowley, John D. Shaughnessy, Matthew J. Scanlan, Ali O. Güre, Bart Barlogie, Madhav V. Dhodapkar - The Journal of Experimental Medicine 2007 被引用: 199

  17. Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients

    著者: Kunle Odunsi, Junko Matsuzaki, Julia Karbach, Antje Neumann, Paulette Mhawech‐Fauceglia, Austin Miller, Amy Beck, Carl D. Morrison, Gerd Ritter, Heidi Godoy, Shashikant Lele, Nefertiti C. duPont, Robert P. Edwards, Protul Shrikant, Lloyd J. Old, Sacha Gnjatic, Elke Jäger - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 被引用: 198

  18. High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma

    著者: Jochen Greiner, Anita Schmitt, Krzysztof Giannopoulos, Markus Rojewski, Mario E. Götz, I. Funk, Mark Ringhoffer, Donald Bunjes, Susanne Hofmann, Gerd Ritter, Hartmut Döhner, Michael Schmitt - Haematologica 2010 被引用: 139

  19. Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase

    著者: Marcus P. Kelly, Achim A. Jungbluth, B-W Wu, John S. Bomalaski, Lloyd J. Old, Gerd Ritter - British Journal of Cancer 2011 被引用: 123

  20. The crystal structure of human CD1d with and without α-galactosylceramide

    著者: Michael Koch, Victoria S. Stronge, Dawn Shepherd, Stephan D. Gadola, Bini Mathew, Gerd Ritter, Alan R. Fersht, Gurdyal S. Besra, Richard R. Schmidt, E. Yvonne Jones, Vincenzo Cerundolo - Nature Immunology 2005 被引用: 389

  21. Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

    著者: Danila Valmori, Naira E. Souleimanian, Valeria Tosello, Nina Bhardwaj, Sylvia Adams, David O’Neill, Anna C. Pavlick, Juliet Escalon, Crystal Cruz, Angelica Angiulli, Francesca Angiulli, Gregory Mears, Susan Vogel, Linda Pan, Achim A. Jungbluth, Eric W. Hoffmann, Ralph Venhaus, Gerd Ritter, Lloyd J. Old, Maha Ayyoub - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 被引用: 295

  22. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

    著者: Kunle Odunsi, Achim A. Jungbluth, Elisabeth Stockert, Feng Qian, Sacha Gnjatic, Jonathan Tammela, Marilyn Intengan, Amy Beck, Bernadette Keitz, Darren Santiago, Barbara Williamson, Matthew J. Scanlan, Gerd Ritter, Yao‐Tseng Chen, Deborah Driscoll, Ashwani Sood, Shashikant Lele, Lloyd J. Old - 2003 被引用: 252

  23. A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

    著者: Andrew M. Scott, Fook-Thean Lee, Niall C. Tebbutt, Rebecca Herbertson, Sanjeev Gill, Zhanqi Liu, Effie Skrinos, Carmel Murone, Timothy Saunder, Bridget Chappell, Anthony T. Papenfuss, Aurora Poon, Wendie Hopkins, Fiona E. Smyth, Duncan MacGregor, Lawrence Cher, Achim A. Jungbluth, Gerd Ritter, Martin W. Brechbiel, Roger Murphy, Antony W. Burgess, Eric W. Hoffman, Terrance G. Johns, Lloyd J. Old - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 被引用: 217

  24. Survey of naturally occurring CD4 + T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

    著者: Sacha Gnjatic, Djordje Atanackovic, Elke Jäger, Mitsutoshi Matsuo, Annamalai Selvakumar, Nasser K. Altorki, Robert G. Maki, Bo Dupont, Gerd Ritter, Yao‐Tseng Chen, Alexander Knuth, Lloyd J. Old - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 被引用: 201